Home
About
Overview
Sharing Data
ORCID
Help
History (1)
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas. Sci Transl Med. 2018 07 04; 10(448).
View in:
PubMed
subject areas
Antineoplastic Agents, Alkylating
Brain Neoplasms
Carbonic Anhydrase II
Cell Differentiation
Cell Line, Tumor
Drug Resistance, Neoplasm
Epithelial-Mesenchymal Transition
Gene Expression Regulation, Neoplastic
Glioma
Humans
Multivariate Analysis
NF-kappa B
Promoter Regions, Genetic
Proportional Hazards Models
Protein Multimerization
Proto-Oncogene Proteins
Survival Analysis
Transcription Factor RelA
Transcription Factors
Xenograft Model Antitumor Assays
authors with profiles
Bakhtiar Yamini
Carrie A. Fitzpatrick
Ralph R. Weichselbaum
Peter Pytel